Dennis Phillip Andrew
Chief Medical Officer
SaleAlert
- Shares
- 8,209
- Price
- $0.71
- Value
- $5,828
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•37 filings
NBP
NovaBridge Biosciences
Net sales of $8.4K over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$8,421
0 buyers · 2 sellers
12-month purchases
$577,300
1 distinct insiders
12-month sales
$31,785
2 distinct insiders
Highlighted alerts
6
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get NBP insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
NBP overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
35
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
29
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 107,978
- Price
- $0.74
- Footnotes
- 4
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting. Reported securities are represented by 46,947 ADSs. Reported sales price represents the converted sales price of the ADSs of $1.6908.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Xu Cong Claire
EVP, Clinical Development
SaleAlert
- Shares
- 3,282
- Price
- $0.79
- Value
- $2,593
Xu Cong Claire
SVP, Clinical Development
SaleAlert
- Shares
- 4,485
- Price
- $0.89
- Value
- $3,992
Dennis Phillip Andrew
Chief Medical Officer
SaleAlert
- Shares
- 8,494
- Price
- $0.66
- Value
- $5,606
Xu Cong Claire
SVP, Clinical Development
SaleAlert
- Shares
- 3,494
- Price
- $3.94
- Value
- $13,766
Hagler Mark Arnold
See Remarks
PurchaseAlert
- Shares
- 230,000
- Price
- $2.51
- Value
- $577,300
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Dennis Phillip Andrew Chief Medical Officer | Sale | 8,209 | $0.71 | $5,828 | |
| Aug 31, 2026 | Xu Cong Claire EVP, Clinical Development | Sale | 3,282 | $0.79 | $2,593 | |
| Jul 06, 2026 | Xu Cong Claire SVP, Clinical Development | Sale | 4,485 | $0.89 | $3,992 | |
| Jun 18, 2026 | Dennis Phillip Andrew Chief Medical Officer | Sale | 8,494 | $0.66 | $5,606 | |
| Jun 01, 2026 | Xu Cong Claire SVP, Clinical Development | Sale | 3,494 | $3.94 | $13,766 | |
| Apr 24, 2026 | Hagler Mark Arnold See Remarks | Purchase | 230,000 | $2.51 | $577,300 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.